ALK and non-small cell lung carcinoma: We presented the typical case of TCM monotherapy achieving remarkable efficacy in the treatment of ALK-positive, crizotinib resistance, and refractory advanced NSCLC with BM, and focused on the feasibility of TCM to alter the prognostic potential of this disease.